The GPR 55 agonist, L‐α‐lysophosphatidylinositol, mediates ovarian carcinoma cell‐induced angiogenesis

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|172|16|4107-4118

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.16, 2015-08, pp. : 4107-4118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca2+ release in rat mesenteric artery endothelial cells

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 12, 2015-06 ,pp. : 3043-3057

John Wiley & Sons Inc

Access to resources Recommend Favorite

GPR35 mediates lodoxamide‐induced migration inhibitory response but not CXCL17‐induced migration stimulatory response in THP‐1 cells; is GPR35 a receptor for CXCL17?

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 1, 2018-01 ,pp. : 154-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation–induced cell death in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 3, 2015-03 ,pp. : 965-978

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Involvement of Protein Kinase D in T Cell-Induced Mast Cell Activation

By  

International Archives of Allergy and Immunology, Vol. 171, Iss. 3-4, 2017-01 ,pp. : 203-208

Karger

Access to resources Recommend Favorite

Leiomyosarcoma with Synchronous Clear Cell Ovarian Carcinoma

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 695-697

Karger

Access to resources Recommend Favorite